Ryan Youland is an Oncology physician affiliated with Minnesota Oncology. OpenAlex indexes 37 publications with 746 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Allergan, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dosimetric patterns of failure in the era of novel chemoradiotherapy in newly-diagnosed glioblastoma patients
Radiotherapy and Oncology
2023 - Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma
Journal of Neuro-Oncology
2022 - 18F-DOPA-PET-Guided Re-Irradiation for Recurrent High-Grade Glioma: Initial Results of a Phase II Trial
International Journal of Radiation Oncology*Biology*Physics
2021 - Pathogenic Germ Line Variants in a Patient With Severe Toxicity From Breast Radiotherapy
Clinical Breast Cancer
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”